Medtronic stock: Medtronic stock gains 3.54 percent against Xetra close

Published on 10/23/2026 at 16:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

First-quarter revenue reached USD 9.76 billion. Medtronic stock costs EUR 85.81 on October 23, 2026, up 3.54 percent versus the Xetra close.

Medtronic gains 3.54 percent

Medtronic stock stood 3.54 percent above the Xetra close on October 23, 2026.
First-quarter fiscal 2027 revenue reached USD 9.76 billion, up 13.70 percent year over year.
Medtronic stock costs EUR 85.81 at Lang & Schwarz on October 23, 2026 at 4:06 p.m. CEST, 3.54 percent above the Xetra close of October 22, 2026.

Schwarzweiß-Dokumentarfoto eines Ingenieurs bei der Prüfung eines Prothesenprototyps — Medtronic plc (ISIN IE00BTN1Y115) Schwarzweiß-Reportage dokumentiert Ingenieur bei Prüfung eines Prothesen-Prototyps im Labor, Illustration mit AI erstellt.

Medtronic stock stood 3.54 percent above the Xetra close of October 22, 2026 on October 23, 2026. The latest reported quarter delivered USD 9.76 billion in revenue, while Zacks reported that adjusted earnings per share reached USD 1.45.

Revenue growth sets the backdrop

Medtronic's first-quarter fiscal 2027 revenue rose 13.70 percent from the prior-year quarter to USD 9.76 billion, according to Zacks. GAAP earnings per share were USD 1.14, compared with USD 0.81 a year earlier, while adjusted operating margin reached 23.70 percent.

The company raised fiscal 2027 organic revenue-growth guidance to 7.25 percent to 7.75 percent from 6.75 percent to 7.25 percent. Adjusted earnings-per-share guidance moved to USD 5.94 to USD 6.00 from USD 5.90 to USD 6.00, with the extra fiscal week contributing to the reported growth.

Stock position and valuation

Medtronic's primary NYSE quote was USD 95.86 on October 23, 2026 at 10:17 a.m. ET. Its 52-week range was USD 73.31 to USD 106.33, leaving the price 9.84 percent below the high. Market capitalization stood at USD 122.6 billion, with a price-to-earnings ratio of 23.59.

Reporting date and peers

Medtronic's next scheduled earnings announcement is November 17, 2026, for the second quarter of fiscal 2027, according to Yahoo Finance. The calendar lists a consensus earnings-per-share estimate of USD 1.33 for that announcement.

Comparison with peers

Medtronic: plus 3.54 percent versus the Xetra close, price-to-earnings ratio 23.59, market capitalization USD 122.6 billion.

Abbott Laboratories (NYSE, USD): down 0.40 percent on October 23, 2026, price-to-earnings ratio 37.84, market capitalization USD 176.7 billion.

Becton, Dickinson and Company (NYSE, USD): down 1.23 percent on October 23, 2026, price-to-earnings ratio 59.57, market capitalization USD 53.9 billion.

European quote remains higher

At Lang & Schwarz, Medtronic was trading at EUR 85.81 on October 23, 2026 at 4:06 p.m. CEST, 3.54 percent above the Xetra close of October 22, 2026 at EUR 82.88. The higher European quote contrasts with the softer same-day moves shown by both comparison companies in US trading.

The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.